TVTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Travere Therapeutics, Inc. and Encourages Investors to Contact the Firm PR Newswire Oct 2, 2024 8:00pm
Calliditas Therapeutics stock jumps as kidney treatment gets FDA approval MarketWatch Dec 21, 2023 1:06pm
Travere Shares Rise 8.4%; Co. To Cut Staff, Focus on IgAN, HCU Treatments Global News Select Dec 4, 2023 9:59pm
Travere Therapeutics shares plunge as kidney-disease treatment has mixed results in trial MarketWatch Sep 21, 2023 12:01pm